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Abstract We aimed to investigate the prevalence of
impaired fasting glucose (IFG) and impaired glucose
tolerance (IGT), and their associations with cardiometabolic
risk factors, according to ethnicity in a large obese
paediatric cohort. A 75-g oral glucose tolerance test was
performed in 1,007 overweight/obese Dutch children of
multi-ethnic origin, referred to the obesity outpatient clinics
of two Dutch hospitals in Amsterdam (mean age, 11.4±
3.2 years; 50.7% boys). Anthropometric parameters and
blood samples were collected, and cardiometabolic risk
factors were assessed. The cohort consisted of Dutch native
(26.0%), Turkish (23.7%), Moroccan (18.8%) and children
of ‘other’ (31.5%) ethnicity. The prevalence of IFG was
significantly higher in Moroccan and Turkish children as
compared to Dutch native children (25.4% and 19.7% vs.
11.8%, respectively, P<0.05). IGT was most frequently
present in Turkish and Dutch native children, relative to
Moroccan children (6.3% and 5.3% vs. 1.6%, P<0.05).
Besides pubertal status and ethnicity, components of
‘metabolic syndrome’ (MetS) which were associated with
IGT, independent of hyperinsulinaemia, were hypertension
[odds ratio (OR), 2.3; 95% CI, 1.1–4.9] while a trend was
seen for high triglycerides (OR, 2.0; 95% CI, 0.9–4.3).
When analyzing components of MetS which were associ-
ated with IFG, only low high-density lipoprotein cholester-
ol was significantly associated (OR, 1.7; 95% CI, 1.2–2.5)
independent of hyperinsulinaemia. In conclusion, in a
Dutch multi-ethnic cohort of overweight/obese children, a
high prevalence of IFG was found against a low prevalence
of IGT, which differed in their associations with cardiome-
tabolic risk factors.
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Introduction
The global rise in the prevalence of obesity, due to
adaptation of a Western lifestyle, has resulted in a high
incidence of type 2 diabetes (T2DM) with the associated
comorbidities and complications, particularly in popula-
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tions with an increased genetic susceptibility [19, 25, 27].
Several cardiometabolic risk factors may precede the
development of aforementioned conditions, i.e. abdominal
obesity, glucometabolic disorders, dyslipidaemia and
hypertension. These entities are deemed to share (at least
in part) similar pathophysiological backgrounds, since
they often cluster within the so-called ‘metabolic syn-
drome’ (MetS) [29]. Although MetS has shown to be
predictive for T2DM, especially the glucometabolic
derangements impose a high risk to develop T2DM [8,
22]. Impaired fasting glucose (IFG) and impaired glucose
tolerance (IGT) seem to differ with respect to their
underlying mechanisms, with varying degrees of insulin
sensitivity, insulin secretion and hepatic glucose output, as
well as glucagon and incretin hormone levels [12, 28].
Moreover, also differences are found between IFG and
IGT as predictors for cardiometabolic outcome measures.
Several studies have shown that 2-h glucose and IGT are
stronger predictors of cardiometabolic events and mortal-
ity as compared to IFG [10, 11, 30]. Varying rates of
prevalence for IFG and IGT are reported among both adult
and paediatric populations. The National Health and
Nutrition Examination Survey (NHANES) study showed
IFG in 26% of the US population≥20 years, while in
children (ages 12–19 years), IFG was present in 13.1%
(>5.6 mmol/L) [6, 20]. In the diabetes epidemiology:
collaborative analysis of diagnostic criteria in Europe
(DECODE) study (ages 30–90 years), IGT was present in
2.9–24.6%, highly dependent on age group [9], while the
prevalence of IGT in children from the NHANES study
was already 3.4% [20]. Besides the data of the NHANES
study, little data have been reported with respect to IFG
and especially IGT in non-clinical populations (non-
overweight children) due to ethical concerns, and are
largely limited to clinical cohorts, i.e. in an obese cohort
of 164 children (ages 4–18 year), the prevalence of IGT
was 22% [33]. These studies have also reported associa-
tions between prevalence rates and ethnicity. Previously,
we found that Turkish children had a more adverse
cardiometabolic risk profile than their peers of Moroccan
origin, although results regarding differences in IFG
versus IGT among ethnic groups remained inconclusive
[38]. It is of importance to know how cardiometabolic risk
factors vary per ethnic population to predict or explain
differences in cardiometabolic outcomes in adulthood.
Since direct comparisons of glucometabolic derange-
ments among ethnic groups are lacking, we aimed to
investigate the prevalence of IFG and IGT according to
ethnicity to identify children who might have increased
risk for developing T2DM/cardiovascular disease (CVD)
and to determine additional associated cardiometabolic
risk for IFG and IGT in a large obese multi-ethnic
paediatric cohort.
Methods
Study population and study protocol
Between March 2004 and June 2009, data were collected
regarding overweight children (aged 3–18 years) who were
referred to the obesity outpatient clinic of either an urban
general hospital (Slotervaart Hospital, n=659) or an academic
hospital (VU University Medical Centre, n=348) in Amster-
dam, the Netherlands. Children were referred to one of the
two hospitals by youth health care or general practitioners.
Children were excluded from the study when diagnosed with
secondary causes of obesity (i.e. hypothyroidism, hypogonad-
ism and pituitary disorders or genetic syndromes), diabetes
and/or when they used glucose- or lipid- lowering medication,
corticosteroids or drugs acting on the central nervous system.
None of the subjects had a history of alcohol abuse, and
serologic tests for hepatitis B or C virus were all negative.
During the first visit, a detailed history and physical
examination was performed, including blood pressure meas-
urements, height, weight and pubertal stage according to
Tanner were assessed [35]. During the second visit, each child
underwent an oral glucose tolerance test (OGTT; 1.75 g/kg
with a maximum of 75 g). In addition, fasting blood samples
were drawn for the assessment of insulin, lipid levels and
alanine aminotransferase (ALT), a marker of non-alcoholic
fatty liver disease [31]. Of the aforementioned tests, ALT was
only determined in the Slotervaart Hospital (n=659).
Definitions
Ethnicity was defined as Dutch if both parents were Dutch
native and Moroccan or Turkish in cases where both parents
were from that specific country. Children with other ethnic-
ities and children with parents of different origins were
collected in a separate group, hereafter referred to as the
‘other’ group. The ‘ethnic minorities’ group existed of all
children who were not classified as Dutch natives. Body mass
index (BMI) was standardized using Z-scores (Z-BMI)
according to Dutch reference values [14].
IGT was defined as a 2-h glucose ≥7.8 and <11.0 mmol/L
and IFG was defined as a fasting glucose 5.6 to 6.9 mmol/L
[41]. In case the values exceeded the upper limit of these
ranges, diabetes was diagnosed. Insulin resistance was
calculated according to the Homeostasis Model Assessment
for Insulin Resistance (HOMA-IR): fasting plasma insulin
(microunits per litre)×fasting glucose (millimoles per litre)/
22.5 [23]. Insulin resistance was defined as HOMA-IR
≥3.5 [18]. Hyperinsulinaemia was present when fasting
plasma insulin was ≥90 pmol/L (prepubertal children) and
≥180 pmol/L (pubertal children) [39]. MetS was diagnosed
according to a definition for children and adolescents as
proposed by Weiss et al. [41] and was established when
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obesity (Z-BMI >2 corresponding with a BMI ≥97th
percentile for age and sex) was present, in addition to two
or more of the following criteria: a triglyceride level ≥95th
percentile for age and sex, a high-density lipoprotein (HDL)
cholesterol level <5th percentile for age and sex, a mean
(systolic or diastolic) blood pressure value ≥95th percentile
for height and sex and IGT [43]. High low-density lipoprotein
(LDL) cholesterol was considered present when levels were
≥95th percentile for age and sex [7], and high ALT levels
above 30 IU/L [17, 37].
Biochemical analyses
Plasma glucose levels, total cholesterol, triglycerides and HDL
cholesterol were measured by standardized validated methods
(SYNCHRON LX20, Beckman Coulter, USA and MODU-
LAR ANALYTICS EVO solution, Roche, Belgium). LDL
cholesterol was calculated by the Friedewald formula [15].
Plasma insulin levels were measured by an immunolumino-
metric assay (Immulite 200 system, DPC, Los Angeles, USA;
intra-assay variation, 3–6%; inter-assay variation, 3–5%) and
ADVIA Centaur insulin assay (Siemens, Netherlands; intra-
assay variation, 4.6%; inter-assay variation, 6%).
Statistical analyses
Mean (standard deviation, SD) or median (interquartile
range, IQR) are shown after stratification for ethnicity.
Differences were tested with χ2 analysis and ANCOVA
(with adjustment for sex, ethnicity, pubertal status and
Table 1 Clinical and metabolic characteristics of overweight/obese subjects by ethnicity
Entire cohort Children of Dutch origin Children of ethnic origin
Number 1,007 262 745
Male (%) 50.7 45.8 52.5
Pubertal (%) 58.5 52.7 60.5*
Age (years) 11.4±3.2 11.5±3.2 11.4±3.2
Z-BMI 2.8±0.5 2.7±0.6 2.8±0.5*
Systolic blood pressure (mmHg) 116±13 116±13 116±13
Diastolic blood pressure (mmHg) 69±9 67±8 69±9*
Fasting glucose (mmol/L) 5.2±0.4 5.1±0.4 5.2±0.4*
Fasting insulin (pmol/L) 110 (72–162) 110 (67–153) 110 (74–167)
HOMA-IR 3.8 (2.5–5.8) 3.9 (2.3–5.6) 3.8 (2.5–6.0)
Total cholesterol (mmol/L) 4.3±0.8 4.3±0.8 4.3±0.8
HDL cholesterol (mmol/L) 1.1 (1.0–1.3) 1.2 (1.0–1.3) 1.1 (0.9–1.3)*
LDL cholesterol (mmol/L) 2.6±0.7 2.6±0.7 2.7±0.7
Triglycerides (mmol/L) 0.8 (0.6–1.2) 0.9 (0.6–1.2) 0.8 (0.6–1.2)
ALT (IU/L)∞ 22 (17–29) 22 (17–27) 22 (17–29)
Prevalence, (%)
Z-BMI>2 (component of the metabolic syndrome) 94.7 91.2 96.0
The metabolic syndrome 15.4 10.3 17.2*
IFG 16.3 13.4 19.2*
IGT 4.9 4.7 5.3
High HDL cholesterol 23.3 12.2 27.2*
High triglycerides 19.5 18.7 19.7
Hypertension 19.3 16.8 20.1
High ALTa 11.1 9.2 11.5
High LDL cholesterol 14.3 16.4 13.6
Insulin resistance 54.1 56.6 54.8
Data are expressed as mean ± SD, N (%) and median (interquartile range) for variables with a skewed distribution. Converting factors, Millimoles
per litre to milligrams per decilitre: glucose, divide by 0.055; HDL/LDL cholesterol, divide by 0.0259; triglycerides, divide by 0.0113. Millimoles
per litre to international units per litre: insulin, divide by 6.945. IFG – impaired fasting glucose, IGT – impaired glucose intolerance.
∞N=657
*P<0.05
aN=657
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Z-BMI). In comparing prevalence rates between groups,
logistic regression with adjustment for confounding
variables (sex, ethnicity, pubertal status and Z-BMI) was
used. Multivariate logistic regression models were used to
determine associations of IFG and/or IGT with cardiome-
tabolic risk (using the NGT group as reference group).
Results of these analyses are expressed as odds ratios (OR)
and 95% confidence intervals (95% CI). Interaction terms
were built in order to determine significant interactions by
ethnicity in the models. These were considered significant
when P<0.1. In the models, the association of hyper-
insulinaemia with IFG and IGT (instead of insulin resistance)
was established, since HOMA-IR includes fasting glucose
in its formula. A P value <0.05 was considered statistically
significant. All analyses were performed with SPSS, version
15.0 (for Windows).
Results
Baseline characteristics
Table 1 shows the baseline characteristics for children of
Dutch origin and children of ethnic origin. The cohort
consisted of 1,007 children (mean age 11.4±3.2 years), of
whom 50.7% were boys and 46.7% were prepubertal. The
main ethnic groups were Dutch native (26.0%), Turkish
(23.7%), Moroccan (18.8%) and ‘other’ (31.5%). The latter
group consisted of over 23 ethnicities, with the largest
subgroup being Surinamese. Almost all children (94.7%)
had a Z-BMI greater then 2 (the reference value of obesity
in MetS) [43]. A total of 16.3% of subjects had IFG,
whereas IGT was only present in 4.9% (see Table 1).
Fourteen children (1.4%) were detected who fulfilled both
IFG and IGT criteria.
Relative to prepubertal children, pubertal children had
a higher frequency of hypertension (15.8% vs. 5.3%, P<
0.001), low HDL cholesterol levels (50.6% vs. 38.8%, P<
0.001), high triglycerides (10.5% vs. 5.5%, P<0.01),
MetS (25.8% vs. 12.4%, P<0.001) and insulin resistance
(69.7% vs. 34.6%, P<0.001), regardless of ethnicity.
Prevalence of IFG and IGT according to ethnicity
Figure 1 presents the prevalence rates of the glucome-
tabolic abnormalities and various cardiometabolic risk
factors according to ethnicity. There were no significant
differences between Z-BMI between the presented
groups. The prevalence of MetS was significantly
higher in Turkish children relative to their peers of
Moroccan and Dutch native origin. Subsequently, insu-
lin resistance (as determined by HOMA-IR) was least
frequently found in Moroccans (as compared to Dutch
native and Turkish children, 45.2 vs. 56.6% and 59.7%,
both P<0.05).
Cardiometabolic risk factors according to glucometabolic
status
Figure 2 shows the prevalence of cardiometabolic risk
factors stratified for glucometabolic status in the entire
cohort. No differences for the association models were
observed between different ethnic groups (i.e. interaction
terms in the models were not significant) Fig. 2.
Hyperinsulinaemia was present in 29.9% of children
with NGT, against 50.6% in IFG children and 50.0% in
IGT children (OR, 2.8; 95% CI, 1.9–4.0 for IFG; OR, 1.8;
95% CI, 1.2–2.7 for IGT, respectively). Moreover, the small
group with combined IFG and IGT showed 71.4% hyper-
insulinaemia (OR of 5.9; 95% CI, 1.8–19.6, as compared to
NGT).
Regarding the components of MetS, independent of
hyperinsulinaemia, children with IGT more frequently
showed hypertension (OR, 2.3; 95% CI, 1.1–4.9), while a
trend was seen for high triglycerides (OR, 2.0; 95% CI,
0.9–4.3) as compared to NGT children. In contrast, IFG
was associated with HDL cholesterol (IFG vs. NGT; OR,
1.7; 95% CI, 1.2–2.5). Although the group who had both
IFG and IGT showed the highest prevalence of components
of the MetS, the association was only significant for
hypertension (OR, 4.0; 95% CI, 1.4–12.1) as compared to
NGT.
Discussion
In a Dutch multi-ethnic cohort of predominantly obese
children, a higher prevalence of IFG (16.3%), rather than
IGT (4.9%) was found. IFG was associated with low HDL
cholesterol while IGT was associated with hypertension,
and a trend was seen towards significance for high
triglycerides.
The prevalence of glucometabolic disorders in the
present study is higher than recently reported in a study
among 535 overweight/obese Italian children, which
reported a prevalence of 7.7% for IFG and 3.2% for IGT
[5]. In contrast, other studies among overweight/obese
children showed lower prevalence rates for IFG (0.1–
0.8%) while showing a higher prevalence for IGT (11.2–
25%), relative to our study [3, 32, 33]. The aforementioned
Fig. 1 Prevalence of impaired fasting glucose, impaired glucose
tolerance, metabolic syndrome, hypertension, low HDL cholesterol,
high triglycerides, high LDL cholesterol, high ALT according to
ethnicity; Dutch native (white bars), Turkish (light grey bars) and
Moroccan (dark grey bars). *P<0.05, ∞ N=657

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differences may be due to the variation in the Tanner stage
of children among the studies [32] or by different lifestyles
(i.e. Turkish and Moroccan people tend to eat more fruits
and vegetables and less saturated fat as compared to Dutch
natives) [4]; however, this would mean that Turkish
children also would present with a more favourable risk
profile. Therefore, it is likely that a great part of the
difference is attributable to variation in genetic profile.
Turkish children showed the highest prevalence of IGT
and insulin resistance, whereas IFG was most frequently
present in Moroccan children who showed the lowest
prevalence of insulin resistance. The present study also
found differences for other cardiometabolic risk factors
among different ethnic groups and was able to show that
Turkish children not only have a more adverse cardiome-
tabolic risk profile as compared to Moroccan children, but
also relative to Dutch native children.
Epidemiological studies report varying conclusions with
respect to cardiometabolic health and ethnic minorities in
adults; however, the social health service of Amsterdam
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Fig. 2 Prevalence of the metabolic syndrome, hypertension, low HDL
cholesterol, high triglycerides and high ALT according to glucometa-
bolic status; normal glucose tolerance (white bars), impaired fasting
glucose (light grey bars), impaired glucose tolerance (dark grey bars)
or presence of both (black bars). *P<0.05, ∞ N=657
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confirmed a higher diabetes prevalence among people of
Turkish and Moroccan origin (three and fourfold higher),
next to higher glucose levels, more unfavourable ratio of
total cholesterol, HDL cholesterol, but lower blood pressure
values [2]. Moreover, a higher prevalence of CVD and
T2DM among Turkish adults living in the Netherlands
was found, in addition to a lower prevalence of CVD
(despite a higher prevalence of T2DM at >45 years)
among Moroccan people living in the Netherlands, as
compared to the Dutch native population [16, 36]. We
have found that the cardiometabolic disadvantage in
people of Turkish origin already starts in childhood, as
Turkish children were shown to have a more adverse
cardiometabolic risk profile as compared to Moroccan and
Dutch native children.
The ‘other’ group generally showed prevalence rates
which were close to the mean prevalence of the entire
cohort, which is attributable to the heterogeneity of this
group. However, impaired glucose tolerance was relatively
often present, which probably results from the relatively
high proportion Hindustani children. It is known that
Hindustani people more frequently present with diabetes
[1, 34].
Regarding cardiometabolic risk in IFG and IGT, our
findings are partly in line with the outcome of the NHANES
study, which showed significantly lower mean HDL choles-
terol and higher mean systolic blood pressure, fasting plasma
insulin and HOMA-IR levels among adolescents with IFG,
relative to adolescents with NGT [20, 21]. In addition, the
strong association between IGT and hyperinsulinaemia was
also confirmed by the latter study, which showed that insulin
resistance played an important role in the pathogenesis of the
transition from NGT to IGT [33]. Conversely, the association
of elevated triglycerides and hypertension with IFG could
not be established in the present article.
Differences in associations between IFG and IGT and
cardiometabolic risk factors may in part be the result of
the markedly higher prevalence of high ALT, (a marker of
liver steatosis and hepatic insulin resistance), which was
found among IGT relative to NGT children and is also
associated with components of the metabolic syndrome in
children [26, 37]. Moreover, they might be explained by
the proposed differences in pathogenic mechanisms of
IFG and IGT. In spite of some common denominators,
IFG is more markedly associated with hepatic insulin
resistance in the presence of (near) normal muscle insulin
sensitivity, whereas IGT has been rather related to
impaired muscle insulin sensitivity and normal to slightly
reduced hepatic insulin resistance [24]. Still, both con-
ditions are due to a decrease in acute beta-cell secretory
response, as was also established in children [42].
Consequently, both IFG and IGT confer an increased risk
of T2DM [40].
In the past, a difference between both glucometabolic
derangements for cardiometabolic mortality has been
reported, underlining the difference in pathophysiology of
the two glucometabolic disorders. According to the DE-
CODE study, increasing fasting glucose levels did not
predict mortality while increasing 2-h glucose values
showed an increase in mortality [11]. In another study,
IFG predicted only overall death from all causes while IGT
was predictive for death from all causes, in addition to
CVD and coronary heart disease [11]. Moreover, it was
concluded that only subjects who converted from IFG to
T2DM had a higher risk of CVD mortality [30]. Until there
is a definite answer to the question how glucometabolic
disorders affect cardiometabolic risks and which role each
glucometabolic disorder fulfills in the development of
T2DM, one can only speculate with regard to the meaning
of the finding of an unusual high prevalence of IFG in the
present cohort. In addition, little information is available
regarding the actual increased cardiometabolic risk of paedi-
atric obesity; however, in a recent study among a large cohort
of American Indian children, with a follow-up of 24 years,
obesity, glucose intolerance and hypertension in childhood
were strongly associated with increased rates of premature
death from endogenous causes while hypercholesterolaemia
was not identified as a major predictor [13].
This study has several limitations. First, due to the cross-
sectional design causal inferences between glucometabolic
disorders, cardiovascular risk factors and ethnicity cannot
be made. Moreover, due to lack of power, no significant
associations between the presence of both IFG and IGT
with cardiometabolic risk factors could be confirmed. In
summary, in this retrospective study we found that
glucometabolic disorders, in particular IFG more than
IGT, are highly prevalent in overweight and obese Dutch
children and adolescents of multi-ethnic origin. Turkish
children showed the most adverse cardiometabolic risk
profile, as compared to Dutch native and Moroccan
children, which suggests an ethnic-specific difference in
T2DM and CVD risk. IFG and IGT did not share similar
associations with other components of MetS. Studies are
warranted which investigate the long-term outcome of the
presence of glucometabolic disorders in childhood on
actual cardiometabolic risk concerning different ethnic
paediatric populations.
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